期刊文献+

异基因造血干细胞移植后慢性移植物抗宿主病危险因素分析 被引量:1

Analysis of risk factors for the development of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
下载PDF
导出
摘要 目的探讨异基因造血干细胞移植后慢性移植物抗宿主病(cGVHD)的发生及其危险因素。方法总结1997年11月至2005年1月治疗的96例患者临床资料,分析了受者年龄、供受者性别、疾病种类、状态、病程、干细胞来源、HLA配型、预处理方案(是否全身照射)、回输细胞数量、移植早期感染、是否发生过急性移植物抗宿主病(aGVHD)等因素与cGVHD发生的关系。结果36例患者发生了cGVHD,发生率为44.4%。发生局限型cGVHD的19例患者的5年生存率为18/19(94.7%),发生广泛型cGVHD的17例患者5年生存率为8/17(47.1%)。两者比较差别有统计学意义(P<0.01)。单因素分析显示:供受者性别、疾病种类、状态、病程,干细胞来源、预处理方案(是否全身照射)、回输细胞数量、移植早期感染均与cGVHD的发生无显著相关性(P>0.05)。多因素分析(logistic回归)确定HLA配型不合(RR=2.17,P<0.01)、发生过aGVHD(RR=2.91,P<0.01)是发生cGVHD的主要危险因素。单因素分析显示:受者年龄越大,cGVHD发病危险性越高(P<0.05)。结论HLA配型不合及发生过aGVHD、受者年龄较大是与cGVHD发生相关的危险因素。 Objective To investigate the incidence and risk factors of chronic graft-versus-host disease (cGVHD) after allogeneic haematopoietic stem cell transplantions (HSCT). Methods The clinical data of allo-HSCT in 96 patients from November 1997 to January 2005 was analyzed. Results cGVHD was developed in 36 cases(44.4% ). The 5-year survival rate for local cGVHD was 8/17 (47.1% ), while that for extenstive cGVHD was 8/17 (47.1%. Tweleve possible factors correlated with the development of cGVHD was analyzed. The univariate analysis showed that donor and recipient g sex, the diagnosis , ststus or stage of disease, stem cell source, conditioning regimen (TBI/without TBI), stem cell number and neutropenic infection were not closely associated with the occurance of cGVHD (P 〉 0.05). On the logistic regression model, 2 independent factors for cGVHD were identified. HLA mismatch( RR = 2.17 ,P 〈 0.01 ) and occurred aGVHD ( RR = 2.91, P 〈 0.01 ). In addition, the univariate analysis showed the cGVHD was strongly associated with the older patients ( P 〈 0.05 ). Conclusion cGVHD is a common complication after HSCT, HLA mismatch, occurred aGVHD and recipient's older age are independent risk factors for cGVHD.
出处 《中国医刊》 CAS 2007年第12期41-43,共3页 Chinese Journal of Medicine
关键词 造血干细胞移植 异基因 慢性移植物抗宿主病 血液病 Haematopoietic stem cell transplantation allogeneic Chronic Graft-versus-host disease leukemia lym-phoma
  • 相关文献

参考文献6

  • 1Fraser C J, Bhatia S, Ness K, et al. Impact of chronic graft-versushost disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study [ J ]. Blood, 2006,108 ( 8 ) : 2867 - 2873.
  • 2Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers [ J ]. New Engl J Med, 2001,344: 175 -181.
  • 3Van-Besien K. Standardizing chronic graft-versus-host disease [ J ]. Future-Oncol,2006 ,2(4):459-462.
  • 4Georgia B. Vogelsang. How I treat chronic graft-versus-host disease [J]. Bleod ,2001,97: 1196 - 1201.
  • 5Ratanatharathorn, L Ayash, HM Lazarus, et al. Chronic graft-versus- host disease : clinical manifestation and therapy [ J ]. Bone Marrow Transplantation,2001,28: 121 - 129.
  • 6Donna Przepiorka, Paolo Anderlini, Rima Saliba, et al. Chronic graft- versus-host disease after allogeneie blood stem cell transplantation [ J]. Blood ,2001,98: 1695 - 1699.

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部